Back to Search
Start Over
OA14 Phase 2 Study: Tepotinib + Gefitinib in MET+/Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
- Source :
- Journal of Thoracic Oncology. 13:S1049-S1050
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
- Subjects :
- 0301 basic medicine
Pulmonary and Respiratory Medicine
biology
business.industry
Mutant
Phases of clinical research
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Gefitinib
Oncology
030220 oncology & carcinogenesis
Cancer research
medicine
biology.protein
Epidermal growth factor receptor
Non small cell
business
Lung cancer
medicine.drug
Subjects
Details
- ISSN :
- 15560864
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Journal of Thoracic Oncology
- Accession number :
- edsair.doi...........bf2635954c7d1962ecb3c0e159208aa3
- Full Text :
- https://doi.org/10.1016/j.jtho.2018.10.024